Format

Send to

Choose Destination
See comment in PubMed Commons below
Sultan Qaboos Univ Med J. 2013 Nov;13(4):502-9. Epub 2013 Nov 8.

The Identification of Pompe Disease Mutations in Archival Tissues and Development of a Rapid Molecular-based Test.

Author information

1
Department of Biology, College of Science, Sultan Qaboos University, Muscat, Oman.

Abstract

OBJECTIVES:

Pompe disease (glycogen storage disease type II) is a rare autosomal recessive lysosomal storage disease that is caused by acid alpha-glucosidase deficiency. Early enzyme replacement therapy can benefit infants with the disease but the diagnosis is complicated by the rarity of the disease and the heterogeneity of the clinical manifestations. In this study, DNA extracted from archival postmortem formalin-fixed paraffin-embedded tissues was used to identify Pompe disease mutations in Oman and develop a rapid molecular-based test.

METHODS:

Intronic primers were designed to amplify short fragments (193-454 base pairs [bp]) from coding exons (2-20) and screen for mutations using direct sequencing (DS).

RESULTS:

Two mutations known to cause severe disease were identified in two samples. One was a coding mutation, c.2560C>T (p.Arg854X), and the second was found at a splice acceptor site, c.1327-2A>G. Polymerase chain reaction- and restriction fragment length polymorphism-based tests were designed for the rapid genotyping of the identified mutations.

CONCLUSION:

These tests can facilitate prenatal diagnosis and help in identifying carriers in families with the identified mutations.

KEYWORDS:

Genotyping Techniques; Glucan 1,4-alpha-Glucosidase; Mutations; Oman; Pompe Disease; Tissue

PMID:
24273659
PMCID:
PMC3836638
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center